Search research articles
Contact Us
Filters
Showing results (41-50 of 97) with videos related to
Page
of 10
Sort By:
Frontiers in Oncology
|
January 19, 2024
Multimodality treatment in recurrent/metastatic squamous cell carcinoma of head and neck: current therapy, challenges, and future perspectives
Sergio Pannunzio, Armando Di Bello, Denis Occhipinti, et al.
Expert Opinion on Drug Safety
|
February 2, 2020
A multidisciplinary expert opinion on CINV and RINV, unmet needs and practical real-life approaches
Paolo Bossi, Mario Airoldi, Maria Antonietta Aloe Spiriti, et al.
Critical Reviews in Oncology/Hematology
|
May 17, 2026
Immunotherapeutic strategies in HPV-positive and HPV-negative recurrent/metastatic oropharyngeal squamous cell carcinoma: from PD-1 blockade to EGFR-directed bispecifics and therapeutic HPV vaccines
Armando Di Bello, Riccardo Gili, Renato Falcicchia, et al.
Future Oncology (London, England)
|
April 26, 2017
DEBIRI plus capecitabine: a treatment option for refractory liver-dominant metastases from colorectal cancer
Vincenzo Di Noia, Michele Basso, Valentina Marsico, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 16, 2015
PDGFRA-mutant syndrome
Riccardo Ricci, Maurizio Martini, Tonia Cenci, et al.
Molecular Diagnosis & Therapy
|
November 28, 2015
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study
Vincenzo Dadduzio, Michele Basso, Sabrina Rossi, et al.
Medicine
|
May 20, 2016
Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases: A Retrospective, STROBE-Compliant, Single-Center Study Comparing Chemotherapy Alone and Combination Chemotherapy With Cetuximab or Bevacizumab
Michele Basso, Vincenzo Dadduzio, Francesco Ardito, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
December 11, 2012
Chance of cure following liver resection for initially unresectable colorectal metastases: analysis of actual 5-year survival
Francesco Ardito, Maria Vellone, Alessandra Cassano, et al.
Pathology Oncology Research : POR
|
March 21, 2018
Erlotinib for Patients with EGFR Wild-Type Metastatic NSCLC: a Retrospective Biomarkers Analysis
Alessandro Inno, Vincenzo Di Noia, Maurizio Martini, et al.
In Vivo (Athens, Greece)
|
September 9, 2017
RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer
Ernesto Rossi, Cinzia Bagalà, Frediano Inzani, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 97) with videos related to
Sort By:
Page
of 10
Frontiers in Oncology
|
January 19, 2024
Multimodality treatment in recurrent/metastatic squamous cell carcinoma of head and neck: current therapy, challenges, and future perspectives
Sergio Pannunzio, Armando Di Bello, Denis Occhipinti, et al.
Expert Opinion on Drug Safety
|
February 2, 2020
A multidisciplinary expert opinion on CINV and RINV, unmet needs and practical real-life approaches
Paolo Bossi, Mario Airoldi, Maria Antonietta Aloe Spiriti, et al.
Critical Reviews in Oncology/Hematology
|
May 17, 2026
Immunotherapeutic strategies in HPV-positive and HPV-negative recurrent/metastatic oropharyngeal squamous cell carcinoma: from PD-1 blockade to EGFR-directed bispecifics and therapeutic HPV vaccines
Armando Di Bello, Riccardo Gili, Renato Falcicchia, et al.
Future Oncology (London, England)
|
April 26, 2017
DEBIRI plus capecitabine: a treatment option for refractory liver-dominant metastases from colorectal cancer
Vincenzo Di Noia, Michele Basso, Valentina Marsico, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 16, 2015
PDGFRA-mutant syndrome
Riccardo Ricci, Maurizio Martini, Tonia Cenci, et al.
Molecular Diagnosis & Therapy
|
November 28, 2015
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study
Vincenzo Dadduzio, Michele Basso, Sabrina Rossi, et al.
Medicine
|
May 20, 2016
Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases: A Retrospective, STROBE-Compliant, Single-Center Study Comparing Chemotherapy Alone and Combination Chemotherapy With Cetuximab or Bevacizumab
Michele Basso, Vincenzo Dadduzio, Francesco Ardito, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
December 11, 2012
Chance of cure following liver resection for initially unresectable colorectal metastases: analysis of actual 5-year survival
Francesco Ardito, Maria Vellone, Alessandra Cassano, et al.
Pathology Oncology Research : POR
|
March 21, 2018
Erlotinib for Patients with EGFR Wild-Type Metastatic NSCLC: a Retrospective Biomarkers Analysis
Alessandro Inno, Vincenzo Di Noia, Maurizio Martini, et al.
In Vivo (Athens, Greece)
|
September 9, 2017
RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer
Ernesto Rossi, Cinzia Bagalà, Frediano Inzani, et al.
Page
of 10